Comparative Benchmarking
In the context of the broader market, INKT competes directly with industry leaders such as MREO and TIL. With a market capitalization of $49.38M, it holds a significant position in the sector. When comparing efficiency, INKT's gross margin of N/A stands against MREO's 73.40% and TIL's N/A. Such benchmarking helps identify whether Mink Therapeutics Inc is trading at a premium or discount relative to its financial performance.
